Waning antibodies in measles and rubella vaccinees - A longitudinal study

Vaccine

Volumn 24, Issue 14, 2006, Pages 2594-2601

  Kremer, Jacques R ^a   Schneider, François ^b   Muller, Claude P ^a  

^a WHO Collaborative Centre for Measles   (Luxembourg)

^b LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

Author keywords

Follow up; Measles and rubella IgG; Vaccination

Indexed keywords

IMMUNOGLOBULIN G; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES MUMPS VACCINE; MEASLES VACCINE; MMRII; RUBELLA ANTIBODY;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL OBSERVATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOLUTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGICAL MONITORING; INFECTION CONTROL; INFECTION SENSITIVITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL AGE; MEASLES; MEASLES VACCINATION; MULTIPLE DRUG DOSE; PRIORITY JOURNAL; REVACCINATION; RUBELLA; SCHOOL CHILD; SECONDARY IMMUNE RESPONSE; SEROPREVALENCE; SINGLE DRUG DOSE; VACCINATION; VIRUS IMMUNITY;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LONGITUDINAL STUDIES; MEASLES; MEASLES VACCINE; MEASLES VIRUS; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; VACCINES, COMBINED;

EID: 33344465264     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.12.015     Document Type: Article

References (38)

1. CDC. Update: Global measles control and mortality reduction - worldwide, 1991-2001. MMWR Morb Mortal Wkly Rep 2003;52(20):471-5.
2. C.A. de Quadros Can measles be eradicated globally? Bull World Health Organ 82 2 2004 134 138 [Epub 2004 Mar 16]
3. W.A. Orenstein, P.M. Strebel, M. Papania, R.W. Sutter, W.J. Bellini, and S.L. Cochi Measles eradication: is it in our future? Am J Public Health 90 10 2000 1521 1525
4. C.P. Muller, and M.N. Mulders Molecular epidemiology of measles virus T. Leitner The molecular epidemiology of human viruses 2002 Kluwer Academic Publishers Boston 237 272
5. F. Hanses, R. van Binnendijk, W. Ammerlaan, A.T. Truong, L. de Rond, and F. Schneider Genetic variability of measles viruses circulating in the Benelux Arch Virol 145 3 2000 541 551
6. CDC. Progress toward measles elimination - region of the Americas, 2002-2003. MMWR Morb Mortal Wkly Rep 2004;53(14):304-6.
7. Panum P. Observations made during the epidemic of measles on the Faroe Islands in the year 1849. Med Classics 1938;3:829-86.
8. D. Guris, J. McCready, J.C. Watson, W.L. Atkinson, J.L. Heath, and W.J. Bellini Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting from exposure to measles virus Pediatr Infect Dis J 15 12 1996 1082 1086
9. T.L. Gustafson, A.W. Lievens, P.A. Brunell, R.G. Moellenberg, C.M. Buttery, and L.M. Sehulster Measles outbreak in a fully immunized secondary-school population N Engl J Med 316 13 1987 771 774
10. I.R. Pedersen, C.H. Mordhorst, G. Glikmann, and H. von Magnus Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland Vaccine 7 4 1989 345 348
11. B. Christenson, and M. Bottiger Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults Vaccine 12 1 1994 41 45
12. I. Davidkin, H. Peltola, P. Leinikki, and M. Valle Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland Vaccine 18 27 2000 3106 3112
13. J.E. Banatvala, and D.W. Brown Rubella Lancet 363 9415 2004 1127 1137
14. B. Christenson, and M. Bottiger Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus Vaccine 12 2 1994 129 133
15. B. Dai, Z.H. Chen, Q.C. Liu, T. Wu, C.Y. Guo, and X.Z. Wang Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China Bull World Health Organ 69 4 1991 415 423
16. I. Davidkin, and M. Valle Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts Vaccine 16 20 1998 2052 2057
17. S. Krugman Further-attenuated measles vaccine: characteristics and use Rev Infect Dis 5 3 1983 477 481
18. M.S. Lee, L.J. Chien, Y.Y. Yueh, and C.F. Lu Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan Vaccine 19 32 2001 4644 4651
19. J. Mossong, C.J. O'Callaghan, and S. Ratnam Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population Vaccine 19 4-5 2000 523 529
20. J. Mossong, L. Putz, and F. Schneider Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study Epidemiol Infect 132 1 2004 11 18
21. S. Ratnam, R. West, V. Gadag, B. Williams, and E. Oates Immunity against measles in school-aged children: implications for measles revaccination strategies Can J Public Health 87 6 1996 407 410
22. S. van den Hof, G.A. Berbers, H.E. de Melker, and M.A. Conyn-van Spaendonck Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage Vaccine 18 9-10 1999 931 940
23. H.D. Dopatka, and B. Giesendorf Single point quantification of antibody by ELISA without need of a reference curve J Clin Lab Anal 6 6 1992 417 422
24. J. Mossong, and C.P. Muller Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population Epidemiol Infect 124 2 2000 273 278
25. J.R. Kremer, F.B. Bouche, F. Schneider, and C.P. Muller Re-exposure to wild-type virus stabilizes measles-specific antibody levels in late convalescent patients J Clin Virol 2005
26. M.G. Cusi, G.M. Rossolini, P.E. Valensin, C. Cellesi, and A. Zanchi Serological evidence of reinfection among vaccinees during rubella outbreak Lancet 336 8722 1990 1071
27. M.G. Cusi, P.E. Valensin, and C. Cellesi Possibility of reinfection after immunisation with RA27/3 live attenuated rubella virus Arch Virol 129 1-4 1993 337 340
28. S. O'Shea, J.M. Best, and J.E. Banatvala Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus J Infect Dis 148 4 1983 639 647
29. L.E. Markowitz, S.R. Preblud, W.A. Orenstein, E.Z. Rovira, N.C. Adams, and C.E. Hawkins Patterns of transmission in measles outbreaks in the United States N Engl J Med 320 2 1989 75 81
30. R.G. Mathias, W.G. Meekison, T.A. Arcand, and M.T. Schechter The role of secondary vaccine failures in measles outbreaks Am J Public Health 79 4 1989 475 478
31. M. Hirose, Y. Hidaka, C. Miyazaki, K. Ueda, and H. Yoshikawa Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination Scand J Infect Dis 29 2 1997 187 190
32. M.A. Reyes, M.F. de Borrero, J. Roa, G. Bergonzoli, and N.G. Saravia Measles vaccine failure after documented seroconversion Pediatr Infect Dis J 6 9 1987 848 851
33. F.R. Smith, A.S. Curran, K.A. Raciti, and F.L. Black Reported measles in persons immunologically primed by prior vaccination J Pediatr 101 3 1982 391 393
34. C.P. Muller, S. Huiss, and F. Schneider Secondary immune responses in parents of children with recent measles Lancet 348 9038 1996 1379 1380
35. R.L. de Swart, S. Yuksel, and A.D. Osterhaus Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization J Virol 79 17 2005 11547 11551
36. B.J. Cohen, R.P. Parry, D. Doblas, D. Samuel, L. Warrener, and N. Andrews Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay J Virol Methods 2005
37. M. Paunio, H. Peltola, M. Valle, I. Davidkin, M. Virtanen, and O.P. Heinonen Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine J Epidemiol Community Health 53 3 1999 173 178
38. C.R. Vitek, M. Aduddell, M.J. Brinton, R.E. Hoffman, and S.C. Redd Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine Pediatr Infect Dis J 18 7 1999 620 623